InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

AJ

Ackerman Joel

Chief Financial Officer

CFOM

DAVITA INC.Champions Oncology, INC.

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€13m

▼ Sales (2 ops.)

Insider track record

CFO

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the full record of transactions filed by Ackerman Joel, Chief Financial Officer. Insider active across 2 companies, notably DAVITA INC.. Aggregated, 32 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €13.1m. Activity tracked since 15 May 2021. The latest transaction was disclosed on 15 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Ackerman Joel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

DAVITA INC. (US)Champions Oncology, INC. (US)

Declarations32 total

●

CFO and TreasurerExecutives15 Mar 2026DAVITA INC.

$506,72131SEC ↗

3,362 shares@ US$150.720.0035% mcap0.6% of flowCommon StockSEC:0000927066-26-000038:1

●

CFO and TreasurerExecutives15 Mar 2026DAVITA INC.

33,693 shares@ US$150.720.035% mcap6.0% of flowCommon StockSEC:0000927066-26-000038:2

●

CFO and TreasurerExecutives15 Mar 2026DAVITA INC.

$868,90131SEC ↗

5,765 shares@ US$150.720.0060% mcap1.0% of flowCommon StockSEC:0000927066-26-000038:3

◆

CFO and TreasurerExecutives15 Mar 2026DAVITA INC.

5,706 shares0Common StockSEC:0000927066-26-000038:0

◆

CFO and TreasurerExecutives10 Mar 2026DAVITA INC.

6,585 shares0Common StockSEC:0000927066-26-000017:0

◇

CFO and TreasuerExecutives6 Feb 2026DAVITA INC.

44,065 shares@ US$108.930.032% mcap11.8% of flowCommon StockSEC:0000927066-26-000008:0

◇

DirectorExecutives30 Oct 2025Champions Oncology, INC.

$198,25128SEC ↗

94,405 shares@ US$2.1027.4% of flowCommon StockSEC:0001628280-25-049954:0

●

CFO and TreasuerExecutives15 Mar 2025DAVITA INC.

$443,69122SEC ↗

3,093 shares@ US$143.450.6% of flowCommon StockSEC:0000927066-25-000056:1

●

CFO and TreasuerExecutives15 Mar 2025DAVITA INC.

$477,83222SEC ↗

3,331 shares@ US$143.450.6% of flowCommon StockSEC:0000927066-25-000056:2

◆

CFO and TreasuerExecutives15 Mar 2025DAVITA INC.

5,995 shares0Common StockSEC:0000927066-25-000056:0

◆

CFO and TreasuerExecutives12 Mar 2025DAVITA INC.

7,394 shares0Common StockSEC:0000927066-25-000018:0

◇

DirectorExecutives31 Oct 2024Champions Oncology, INC.

$185,78718SEC ↗

88,470 shares@ US$2.1037.7% of flowCommon StockSEC:0001628280-24-044663:0

◇

CFO and TreasuerExecutives16 Sept 2024DAVITA INC.

78,999 shares@ US$75.957.4% of flowCommon StockSEC:0000927066-24-000167:0

●

CFO and TreasuerExecutives16 Sept 2024DAVITA INC.

36,684 shares@ US$163.567.4% of flowCommon StockSEC:0000927066-24-000167:1

●

CFO and TreasuerExecutives16 Sept 2024DAVITA INC.

21,602 shares@ US$163.564.3% of flowCommon StockSEC:0000927066-24-000167:2

▼

CFO and TreasuerExecutives27 Aug 2024DAVITA INC.

64,029 shares@ US$155.063912.1% of flowCommon StockSEC:0000927066-24-000157:0

◆

CFO and TreasuerExecutives14 Mar 2024DAVITA INC.

14,349 shares0Common StockSEC:0000927066-24-000043:0

◇

CFO and TreasuerExecutives6 Mar 2024DAVITA INC.

55,000 shares@ US$52.413.6% of flowCommon StockSEC:0000927066-24-000034:0

◇

CFO and TreasuerExecutives21 Feb 2024DAVITA INC.

55,000 shares@ US$52.413.6% of flowCommon StockSEC:0000927066-24-000024:0

◇

DirectorExecutives17 Oct 2023Champions Oncology, INC.

$240,55919SEC ↗

114,552 shares@ US$2.1050.2% of flowCommon StockSEC:0001628280-24-000639:0

●

CFO and TreasuerExecutives15 May 2023DAVITA INC.

$738,55822SEC ↗

7,625 shares@ US$96.860.9% of flowCommon StockSEC:0000927066-23-000145:0

◇

CFO and TreasuerExecutives10 May 2023DAVITA INC.

56,306 shares@ US$66.294.6% of flowCommon StockSEC:0000927066-23-000107:0

◆

CFO and TreasuerExecutives4 Apr 2023DAVITA INC.

2,790 shares0Common StockSEC:0000927066-23-000075:0

◆

CFO and TreasuerExecutives15 Mar 2023DAVITA INC.

23,672 shares0Common StockSEC:0000927066-23-000067:0

◆

CFO and TreasuerExecutives9 Mar 2023DAVITA INC.

1,387 shares0Common StockSEC:0000927066-23-000030:0

25 of 32 declarations

About Ackerman Joel

ACKERMAN JOEL is Directeur Financier. He has 32 filings in total, and across the sampled recent filings, the transactions cover the period from 2021-05-18 to 2026-03-17, with EUR 18464230 in sales and EUR 0 in purchases. His listed companies are DAVITA INC., where he is CFO and Treasurer, and Champions Oncology, INC., where he is Director.